The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kuchina A.Yu.

Sechenov First Moscow State Medical University

Novikova N.A.

Sechenov First Moscow State Medical University

Suvorov A.Yu.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Bykova A.A.

Sechenov First Moscow State Medical University

Salpagarova Z.K.

Sechenov First Moscow State Medical University

Vorontsov N.V.

Sechenov First Moscow State Medical University

Osipova A.I.

Sechenov First Moscow State Medical University

Advanced age patients with atrial fibrillation. 3-year observational study

Authors:

Kuchina A.Yu., Novikova N.A., Suvorov A.Yu., Bykova A.A., Salpagarova Z.K., Vorontsov N.V., Osipova A.I.

More about the authors

Read: 2903 times


To cite this article:

Kuchina AYu, Novikova NA, Suvorov AYu, Bykova AA, Salpagarova ZK, Vorontsov NV, Osipova AI. Advanced age patients with atrial fibrillation. 3-year observational study. Russian Journal of Cardiology and Cardiovascular Surgery. 2021;14(5):392‑399. (In Russ.)
https://doi.org/10.17116/kardio202114051392

Recommended articles:
Left atrial redu­ction in mitral valve surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):460-470
Current approaches to the prevention and treatment of post-thrombotic syndrome. Russian Journal of Preventive Medi­cine. 2025;(5):111-116

References:

  1. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort:the Framingham Heart Study. JAMA. 1994;271:11:840-844.  https://doi.org/10.1001/jama.1994.03510350050036
  2. Golzari H, Cebul RD, Bahler RC. Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy. Ann Intern Med. 1996;125:4:311-323.  https://doi.org/10.7326/0003-4819-125-4-199608150-00010
  3. Fedorova MKh, Doshchitsyn VL, Chapurnykh AV. Antiarrhythmic therapy in comorbid elderly and senile patients with paroxysmal and recurrent atrial fibrillation. Rational Pharmacotherapy in Cardiology. 2018;14:5:670-677. (In Russ.). https://doi.org/10.20996/1819-6446-2018-14-5-670-6
  4. Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features,epidemiology, and mechanisms. Circulation research. 2014;114:9:1453-1468.
  5. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837-847. 
  6. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949-953. 
  7. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042-1046.
  8. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263-272. 
  9. Kilickap M, Bosch J, Eikelboom JW, Hart RG. Antithrombotic treatments for stroke prevention in elderly patients with non-valvular atrial fibrillation: Drugs and doses. Can J Cardiol. 2016;32:9:1108-1116.
  10. Akao M, Chun YH, Esato M, et al. Inappropriate use of oral anticoagulants for patients with atrialfibrillation. Circ J. 2014;78:2166-2172.
  11. Kuchina AYu, Novikova NA, Suvorov AYu, Shidlovskaya SA, Arshinova IA. Characteristics of elderly and senile patients with atrial fibrillation in clinical practice. Cardiology and Cardiovascular Surgery. 2019;12:3:213-221. (In Russ.). https://doi.org/10.17116/kardio201912031213
  12. Marijon E, Le Heuzey JY, Connolly S, et al. RE-LY Investigators. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation. 2013;128:20:2192-2201. https://doi.org/10.1161/CIRCULATIONAHA.112.000491
  13. Jabre P, Roger VL, Murad MH, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and metaanalysis. Circulation. 2011;123:1587-1593. https://doi.org/10.1161/CIRCULATIONAHA.110.986661
  14. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation:a systematic review. Neurology. 2007;69:6:546-554. 
  15. Napalkov DA, Sokolova AA. Elderly patients with atrial fibrillation: a focus on comorbidity and safety of anticoagulation. Rational Pharmacotherapy in Cardiology. 2019;15:4:553-557. (In Russ.). https://doi.org/10.20996/1819-6446-2019-15-4-553-557
  16. Kim HM, Choi EK, Park CS, et al. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in octogenarian patients with nonvalvular atrial fibrillation. PLoS ONE. 2019;14:3:e0211766. https://doi.org/10.1371/journal.pone.0211766
  17. Ouyang AJ, Lv YN, Zhong HL, et al. Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation. Am J Cardiol. 2015;115:901-906.  https://doi.org/10.1016/j.amjcard.2015.01.013
  18. Vamos M, Erath JW, Hohnloser SH. Digoxin-associated mortality: a systematic review and meta-analysis of the literature. Eur Heart J. 2015;36:1831-1838. https://doi.org/10.1093/eurheartj/ehv143
  19. Ziff OJ, Kotecha D. Digoxin: the good and the bad. Trends in Cardiovascular Medicine. 2016;26:7:585-595.  https://doi.org/10.1016/j.tcm.2016.03.011
  20. Ziff OJ, Lane DA, Samra M, et al. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ. 2015;351:h4451.
  21. Emara MK, Saadet AM. Transient atrial fibrillation in hypertensive patients with thiazide induced hypokalaemia. Postgraduate Medical Journal. 1986;62:1125-1127. https://doi.org/10.1136/pgmj.62.734.1125

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.